Skip to content

The association of zinc transporter ZIP8 expression levels with concentration of ZIP8 transported substrates in synovial fluid, plasma synovial membrane and cartilage of OA patients

The association of zinc transporter ZIP8 expression levels with concentration of ZIP8 transported substrates in synovial fluid, plasma synovial membrane and cartilage of OA patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17013083
Enrollment
Unknown
Registered
2017-10-23
Start date
2017-11-01
Completion date
Unknown
Last updated
2017-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis

Interventions

osteoarthritic group:none
control group:none

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meet the knee osteoarthritis diagnostic standard of Primary OA of the American Rheumatism Association criteria; 2. OA Patients with Kellgren-Lawrence grade IV; 3. Undergoing total knee arthroplasty;Inclusion criteria: 1. Meet the knee osteoarthritis diagnostic standard of Primary OA of the American Rheumatism Association criteria; 2. OA Patients with Kellgren-Lawrence grade IV; 3. Undergoing total knee arthroplasty;Inclusion criteria: 1. Meet the knee osteoarthritis diagnostic standard of Primary OA of the American Rheumatism Association criteria; 2. OA Patients with Kellgren-Lawrence grade IV; 3. Undergoing total knee arthroplasty;Inclusion criteria: 1. Meet the knee osteoarthritis diagnostic standard of Primary OA of the American Rheumatism Association criteria; 2. OA Patients with Kellgren-Lawrence grade IV; 3. Undergoing total knee arthroplasty;Inclusion criteria: 1. Meet the knee osteoarthritis diagnostic standard of Primary OA of the American Rheumatism Association criteria; 2. OA Patients with Kellgren-Lawrence grade IV; 3. Undergoing total knee arthroplasty

Exclusion criteria

Exclusion criteria: 1. Past history of joint puncture with drug injection; 2. Secondary OA caused by trauma, infection, immune disease, genetic disease or other definite factors; 3. Synovial fluid contaminated with blood.;Exclusion criteria: 1. Past history of joint puncture with drug injection; 2. Secondary OA caused by trauma, infection, immune disease, genetic disease or other definite factors; 3. Synovial fluid contaminated with blood.;Exclusion criteria: 1. Past history of joint puncture with drug injection; 2. Secondary OA caused by trauma, infection, immune disease, genetic disease or other definite factors; 3. Synovial fluid contaminated with blood.;Exclusion criteria: 1. Past history of joint puncture with drug injection; 2. Secondary OA caused by trauma, infection, immune disease, genetic disease or other definite factors; 3. Synovial fluid contaminated with blood.;Exclusion criteria: 1. Past history of joint puncture with drug injection; 2. Secondary OA caused by trauma, infection, immune disease, genetic disease or other definite factors; 3. Synovial fluid contaminated with blood.

Design outcomes

Primary

MeasureTime frame
Plasma Selenium, Copper, Zinc, Iron, Manganese and Cadmium concentrations;Synovial fluid Selenium, Copper, Zinc, Iron, Manganese and Cadmium concentrations;Synovial membrane Selenium, Copper, Zinc, Iron, Manganese and Cadmium concentrations;Cartilage Selenium, Copper, Zinc, Iron, Manganese and Cadmium concentrations;Zip8 mRNA and protein level of cartilage and synovial membrane;

Secondary

MeasureTime frame
MMP3/6/9/13 mRNA and protein level of cartilage and synovial membrane;Selenoproteome level of cartilage and synovial membrane.;

Countries

China

Contacts

Public ContactPengde Kang;Pengde Kang;Pengde Kang;Pengde Kang;Pengde Kang ;;;;

West China Hospital of Sichuan Unniversity;West China Hospital of Sichuan Unniversity;West China Hospital of Sichuan Unniversity;West China Hospital of Sichuan Unniversity;West China Hospital of Sichuan Unniversity

kangpd@163.com;kangpd@163.com;kangpd@163.com;kangpd@163.com;kangpd@163.com+86 18980601953;+86 18980601953;+86 18980601953;+86 18980601953;+86 18980601953

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026